Skip to main content
SpringerLink
Log in

Lipoprotein disorders and cardiovascular risk

  • Published:
Journal of Inherited Metabolic Disease

Abstract

Summary: Disorders of lipoproteins often lead to disease in humans. Most often the sequelae of long-term dyslipoproteinaemia lead to atherosclerotic vascular disease in all arterial beds. Plasma elevation of low-density lipoprotein cholesterol (LDL-C), very low-density lipoproteins (VLDL) and lipoprotein(a), and reduced levels of high-density lipoproteins (HDL-C) are risk factors for coronary artery disease. Severe elevations of plasma triglycerides may lead to acute pancreatitis. In Western societies and in emerging economies, lifestyle contributes to the expression of lipoprotein disorders. Many dyslipoproteinaemias have a genetic aetiology. This review will examine the contribution of genetic lipoprotein disorders in human disease. Emphasis will be placed on monogenic disorders that are associated with coronary artery disease and novel causes of disorders of high-density lipoproteins. The consideration of screening and treatment of affected individuals, especially children, must take into account the severity of the phenotype, the long-term risk of developing vascular disease and available evidence of clinical benefit in a group of diseases that are mostly asymptomatic until manifestations of organ ischaemia in the heart, limbs or brain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  • Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M (1996) Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271: 518-521.

    PubMed  CAS  Google Scholar 

  • Assmann G, Schulte H, von Eckardstein A, Huang Y (1996) High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis 124: S11-20.

    Article  PubMed  CAS  Google Scholar 

  • Berge KE, Tian H, Graf GA, et al (2000) Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 290(5497): 1709 1711.

    Article  Google Scholar 

  • Brooks-Wilson A, Marcil M, Clee S, et al (1999) Mutations in the ATP binding cassette (ABC1) transporter gene in Tangier disease and familial HDL deficiency. Nature Genetics 22: 336-345.

    Article  PubMed  CAS  Google Scholar 

  • Brown MS, Brown JL (1997) The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89: 331-340.

    Article  PubMed  CAS  Google Scholar 

  • Brown MS, Goldstein JL (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232: 34-47.

    PubMed  CAS  Google Scholar 

  • Danesh J, Collins R, Peto R (2000) Lipoprotein (a) and coronary heart disease. Meta-analysis of prospective studies. Circulation 102: 1082-1085.

    PubMed  CAS  Google Scholar 

  • Davignon J, Genest J Jr (1998) Genetic disorders of lipoproteins. Endocrinol Clin North Am 27: 521-549.

    Article  CAS  Google Scholar 

  • de Man FH, de Beer F, van der Laarse A, Smelt AH, Havekes LM (1997) Lipolysis of very low density lipoproteins by heparan sulfate proteoglycan-bound lipoprotein lipase. Lipid Res 38(12): 2465 2472.

    Google Scholar 

  • Emi M, Asaoka H, Matsumoto A, et al (1993) Structure, organization, and chromosomal mapping of the human macrophage scavenger receptor gene. J Biol Chem 268: 2120-2125.

    PubMed  CAS  Google Scholar 

  • Feoli-Fonseca JC, Levy E, Godard M, Lambert M (1998) Familial lipoprotein lipase deficiency in infancy: clinical, biochemical, and molecular study. J Pediatr 133: 417-423.

    Article  PubMed  CAS  Google Scholar 

  • Genest J (2002) Genetics and prevention: a new look at HDL cholesterol. Cardiol Rev 10: 61-71.

    Article  PubMed  Google Scholar 

  • Genest J Jr, Martin-Munley SR, McNamara JR, et al (1992) Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 85: 2025-2033.

    PubMed  Google Scholar 

  • Genest JJ, Marcil M, Denis M, et al (1999) High-density lipoproteins in health and in disease. J Invest Med 47: 31-42.

    Google Scholar 

  • Grundy SM (1997) Small LDL, atherogenic, dyslipidemia, and the metabolic syndrome. Circulation 95: 1-4.

    PubMed  CAS  Google Scholar 

  • Hansen PS, Defesche JC, Kastelein JJP, et al (1997) Phenotypic variation in patients hetero-zygous for familial defective apolipoprotein B (FDB) in three European countries. Arterioscler Thromb Vasc Biol 17: 741-747.

    PubMed  CAS  Google Scholar 

  • Havel RJ, Kane JP (1995) Structure and metabolism of plasma lipoproteins. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic andMolecular Bases of Inherited Disease, 7th edn. New York: McGraw-Hill, 1841 1851.

    Google Scholar 

  • Hiltunen TP, Luoma JS, Nikkari T, Yla-Herttuala S (1998) Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit athe-rosclerotic lesions: marked induction of scavenger receptor and VLDL receptor expression during lesion development. Circulation 97(11): 1079-1086.

    PubMed  CAS  Google Scholar 

  • Kuivenhoven JA, de Knijff P, Boer JM, et al (1997a) Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels. Arterioscler Thromb Vasc Biol 17(3): 560 568.

    PubMed  CAS  Google Scholar 

  • Kuivenhoven JA, Pritchard H, Hill J, Frohlich J, Assmann G, Kastelein J (1997b) The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes. J Lipid Res 38: 191-205.

    PubMed  CAS  Google Scholar 

  • Mahley RW, Huang Y, Rall SC Jr (1999) Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia): questions, quandaries, and paradoxes. J Lipid Res 11: 1933-1949.

    Google Scholar 

  • Marcil M, Brooks-Wilson A, Clee S, et al (1999) Familial HDL deficiency with defective cholesterol efflux is caused by mutations in cholesterol efflux regulatory protein (CERP/ABC1). Lancet 354: 1341-1346.

    Article  PubMed  CAS  Google Scholar 

  • MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomized placebo-controlled trial (2002). Heart Protection Study Collaborative Group. Lancet 360: 7-22.

  • Murray CJL, Lopez AD (1997) Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 349: 1269-1276.

    Article  PubMed  CAS  Google Scholar 

  • Murray I. Kohl J, Cianflone K (1999) Acylation-stimulating protein (ASP): structure function determinants of cell surface binding and triacylglycerol synthetic activity. Biochem J 342(Pt 1): 41-48.

    Article  Google Scholar 

  • Narcisi TME, Shoulders CC, Chester SA, et al (1995) Mutations of the microsomal triglyceride-transfer-protein gene in abetalipoproteinemia. Am JHum Genet 57: 1298-1310.

    PubMed  CAS  Google Scholar 

  • NCEP (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adults Treatment Panel III) (2001). JAMA 285: 2486-2497.

    Article  Google Scholar 

  • O'Connell B, Genest J Jr (2001) High density lipoproteins and endothelial function. Circulation 104: 1978-1983.

    PubMed  Google Scholar 

  • Oram JF (2000) Tangier disease and ABCA1. Biochim Biophys Acta 1529: 321-330.

    PubMed  CAS  Google Scholar 

  • Pajukanta P, Nuotio I, Terwilliger JD, et al (1998) Linkage of familial combined hyperlipidaemia to chromosome lq21 q23. Nature Genetics 18: 369-373.

    Article  PubMed  CAS  Google Scholar 

  • Ridker P, Genest J Jr, Libby P (2000) Plasma lipids and lipoproteins and cardiovascular diseases. In: Libby P, Braunwald E eds. Braunwald's Heart Disease. New York: Saunders; 1010-1039.

    Google Scholar 

  • Ross R (1999) Atherosclerosis an inflammatory disease. N Engl J Med 340(2): 115-126.

    Article  PubMed  CAS  Google Scholar 

  • Santamarina-Fojo S (1998) The familial chylomicronemia syndrome. Endocrinol Metab Clin North Am 27: 551-567.

    Article  PubMed  CAS  Google Scholar 

  • Segrest JP, Jones MK, Klon AE, et al (1999) A detailed molecular belt model for apolipoprotein A-I in discoidal high density lipoprotein. JBiol Chem 274(45): 31755-31758.

    Article  CAS  Google Scholar 

  • Sirtori CR, Calabresi L, Franceschini G, et al (2001) Cardiovascular status of carriers of the apolipoprotein A-I milano. The Limone sul Garda study. Circulation 103: 1949-1954.

    PubMed  CAS  Google Scholar 

  • Sorci-Thomas MG, Thomas MJ (2002) The effects of altered apolipoprotein A-I structure on plasma HDL concentration. Trends Cardiovasc Med 12(3): 121-128.

    Article  PubMed  CAS  Google Scholar 

  • Vance DE, Van den Bosch H (2000) Cholesterol in the year 2000. Biochim Biophys Acta 1529: 1-8.

    PubMed  CAS  Google Scholar 

  • Viana MB, Giugliani R, Leite VHR, et al (1990) Very low levels of high density lipoprotein cholesterol in four sibs of a family with non-neuropathic Niemann Pick disease and sea-blue histiocytosis. J Med Genet 27: 499-504.

    Article  PubMed  CAS  Google Scholar 

  • Weinstock PH, Bisgaier CL, Aalto-Setala K, et al (1995) Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice: mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes. J Clin Invest 96: 2555-2568.

    Article  PubMed  CAS  Google Scholar 

  • Wilson DJ, Gahan M, Haddad L, et al (1998) A World Wide Web site for low-density lipoprotein receptor gene mutations in familial hypercholesterolemia: sequence-based, tabular, and direct submission data handling. Am J Cardiol 81: 1509-1511.

    Article  PubMed  CAS  Google Scholar 

  • Wilson PW (1990) High-density lipoprotein, low-density lipoprotein and coronary artery disease Am J Cardiol 66(6): 7A-10A.

    Article  PubMed  CAS  Google Scholar 

  • Yusuf S, Reddy S, Ounpuu O, Anand S (2001) Global burden of cardiovascular diseases. Circulation 104: 2746-2753.

    PubMed  CAS  Google Scholar 

  • Zhang SH, Reddick RL, Piedrahita JA, Maeda N (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258: 468-471.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiovascular Genetics Laboratory, McGill University Health Center, Royal Victoria Hospital, Montreal, Quebec, Canada

    J. Genest (Director)

Authors
  1. J. Genest
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Genest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Genest, J. Lipoprotein disorders and cardiovascular risk. J Inherit Metab Dis 26, 267–287 (2003). https://doi.org/10.1023/A:1024449603891

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1024449603891

Keywords

Search

Navigation